Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 2 | |
Outperform | 1 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in SEK
The 5 analysts offering 12 month price targets for Xvivo Perfusion AB have a median target of 560.00, with a high estimate of 584.00 and a low estimate of 480.00. The median estimate represents a 11.55% increase from the last price of 502.00.
High | 16.3% | 584.00 |
Med | 11.6% | 560.00 |
Low | -4.4% | 480.00 |
Dividends in SEK
Div growth (TTM) | -- |
---|
More ▼
Earnings history & estimates in SEK
The next earnings announcement is expected on Oct 24, 2024.
Average growth rate | +624.13% |
Average growth rate | +127.44% |
More ▼
Revenue history & estimates in SEK
Average growth rate | +8.40% |
Average growth rate | +32.43% |
More ▼